Skip to main content
. 2022 Jun 2;13(5):13654–13666. doi: 10.1080/21655979.2022.2084246

Figure 5.

Figure 5.

Silencing of LINC00514 attenuated NSCLC tumor growth in vivo. (a) The images of subcutaneous tumors were obtained on Day28. (b) Western-blot showed that knockdown of LINC00514 affected the expression of EMT and Wnt/β-catenin signaling-related proteins in vivo. (C/D) The tumor volumes and weights of the sh-LINC00514/sh-NC group were quantified. Data are presented as the mean ± SD. **p < 0.01, ***p < 0.001. compared with sh-NC group, N = 3.